Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Helminth parasites of impalas, <i>Aepyceros melampus</i>, in eastern southern Africa, collected during 1973 to 2007.

Journal of the South African Veterinary Association·2024
Same author

Major trauma in Older Adults - a retrospective analysis of the Major Trauma Audit.

Irish medical journal·2024
Same author

Development and inter-laboratory validation of the VISAGE enhanced tool for age estimation from semen using quantitative DNA methylation analysis.

Forensic science international. Genetics·2021
Same author

MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer.

Nature communications·2021
Same author

Malignant Transformation of Temporal Bone Schneiderian Papilloma Associated with HPV-6.

Case reports in otolaryngology·2021
Same author

[Right upper abdominal pain, vomiting, weight loss and icterus in a 20-year-old male refugee].

Der Internist·2020

Related Experiment Video

Updated: Jul 2, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

[Interstitial lung diseases].

K Junker1, F Brasch

  • 1Zentrum für Pathologie, Klinikum Bremen-Mitte gGmbH, Bremen, St.-Jürgen-Strasse 1, 28177 Bremen. pathologie@klinikum-bremen-mitte.de

Der Pathologe
|September 4, 2008
PubMed
Summary
This summary is machine-generated.

Interstitial lung diseases (ILDs) are a diverse group of lung conditions. Accurate diagnosis requires pathologists to identify histological patterns, with pulmonologists making the final clinicopathologic diagnosis.

Related Experiment Videos

Last Updated: Jul 2, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Area of Science:

  • Pulmonology
  • Pathology
  • Radiology

Context:

  • Interstitial lung diseases (ILDs) encompass approximately 200 distinct conditions.
  • Classification systems separate ILDs into known causes, granulomatous diseases, and idiopathic interstitial pneumonias (IIPs).
  • The 2002 ATS/ERS consensus classification guides the diagnosis of IIPs.

Purpose:

  • To outline the classification of interstitial lung diseases.
  • To differentiate between various histological patterns of ILDs.
  • To emphasize the collaborative diagnostic process between pathologists and pulmonologists.

Summary:

  • ILDs are classified based on etiology and histological patterns.
  • Key histological patterns include usual interstitial pneumonia (UIP), nonspecific interstitial pneumonia (NSIP), organizing pneumonia (COP), diffuse alveolar damage (DAD), respiratory bronchiolitis (RB), desquamative interstitial pneumonia (DIP), and lymphocytic interstitial pneumonia (LIP).
  • Pathologists identify histological patterns, while pulmonologists integrate clinical and radiological findings for the final diagnosis.

Impact:

  • Highlights the importance of accurate histological pattern recognition in ILD diagnosis.
  • Underscores the necessity of integrating clinical, radiological, and pathological data for definitive ILD diagnosis.
  • Facilitates a standardized approach to ILD classification and diagnosis.